Related Experiment Video
Updated: Mar 2, 2026

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
Published on: January 21, 2018
Cardio-oncology in the older adult
Prajwal Reddy1, Chetan Shenoy2, Anne H Blaes3
1Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA.
Abstract:
Heart disease and cancer are the leading causes of death in older adults. Many first-line cancer treatments have the potential for cardiotoxicity. Age-related risk factors, pre-existing cardiac disease, and a high prevalence of comorbidities are reasons for increased cardiotoxicity in older adults. Concerns regarding cardiotoxicity may lead to frailty bias and undertreatment, resulting in suboptimal outcomes. There is an urgent need for geriatric-specific evidence and guidelines to help tailor care for this vulnerable group. A multi-disciplinary approach based on close collaboration between oncologists, cardiologists, and geriatricians, among other specialist clinicians is essential.
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Cardiomyopathy VI: Nursing Management
Cardiomyopathy V: Interprofessional Care
Heart Failure V: Medical Management
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

